A Phase 1 Study to Evaluate the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of PF-06342674 (RN168) in Adults with Type 1 Diabetes
|Effective start/end date||4/1/14 → 9/30/18|
- PFIZER, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.